Related Experiment Videos
[Fulminant liver failure: etiopathogenesis and therapy]
L Fogli1, P Gorini, E Morsiani
1Divisione di Chirurgia Generale, Ospedale Bellaria, Azienda U.S.L. Città di Bologna.
Annali Italiani Di Chirurgia
|October 3, 2000
Summary
Fulminant hepatic failure (FHF) is a severe liver condition that can be fatal but is potentially reversible. Management includes liver transplantation and novel bio-artificial liver support systems.
Area of Science:
- Hepatology
- Gastroenterology
- Transplantation Surgery
Context:
- Fulminant hepatic failure (FHF) is a rare but serious clinical syndrome.
- Characterized by rapid liver dysfunction and encephalopathy in patients without pre-existing liver disease.
- FHF presents a significant challenge due to its high mortality and potential for reversibility.
Purpose:
- To provide a comprehensive overview of fulminant hepatic failure (FHF).
- To discuss the diverse etiologies, clinical manifestations, and current management strategies for FHF.
- To highlight recent advancements in surgical procedures and bio-artificial liver support systems.
Summary:
- FHF involves acute liver damage leading to encephalopathy within eight weeks.
- Management includes medical therapies, orthotopic liver transplantation, and auxiliary transplantation.
- The paper reviews clinical experience with bio-artificial liver support systems.
Impact:
- Informs clinicians on the latest approaches to managing FHF.
- Highlights the potential of novel treatments like bio-artificial liver support.
- Contributes to improved patient outcomes for this critical condition.